These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 30125542)
1. Toll-Like Receptor-7 Signaling Promotes Nonalcoholic Steatohepatitis by Inhibiting Regulatory T Cells in Mice. Roh YS; Kim JW; Park S; Shon C; Kim S; Eo SK; Kwon JK; Lim CW; Kim B Am J Pathol; 2018 Nov; 188(11):2574-2588. PubMed ID: 30125542 [TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis. Roh YS; Park S; Kim JW; Lim CW; Seki E; Kim B Hepatology; 2014 Jul; 60(1):237-49. PubMed ID: 24375615 [TBL] [Abstract][Full Text] [Related]
4. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells. Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW J Leukoc Biol; 2010 Jan; 87(1):117-25. PubMed ID: 19843574 [TBL] [Abstract][Full Text] [Related]
5. Mainstream cigarette smoke accelerates the progression of nonalcoholic steatohepatitis by modulating Kupffer cell-mediated hepatocellular apoptosis in adolescent mice. Park S; Kim JW; Yun H; Choi SJ; Lee SH; Choi KC; Lim CW; Lee K; Kim B Toxicol Lett; 2016 Aug; 256():53-63. PubMed ID: 27180087 [TBL] [Abstract][Full Text] [Related]
6. 3, 3'-Diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance. Liu Y; She W; Wang F; Li J; Wang J; Jiang W Int Immunopharmacol; 2014 Dec; 23(2):489-98. PubMed ID: 25281898 [TBL] [Abstract][Full Text] [Related]
7. Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice. Petrasek J; Dolganiuc A; Csak T; Kurt-Jones EA; Szabo G Gastroenterology; 2011 Feb; 140(2):697-708.e4. PubMed ID: 20727895 [TBL] [Abstract][Full Text] [Related]
8. Lack of FGF21 promotes NASH-HCC transition Zheng Q; Martin RC; Shi X; Pandit H; Yu Y; Liu X; Guo W; Tan M; Bai O; Meng X; Li Y Theranostics; 2020; 10(22):9923-9936. PubMed ID: 32929325 [No Abstract] [Full Text] [Related]
9. Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-β signaling. Bourgeois C; Majer O; Frohner IE; Lesiak-Markowicz I; Hildering KS; Glaser W; Stockinger S; Decker T; Akira S; Müller M; Kuchler K J Immunol; 2011 Mar; 186(5):3104-12. PubMed ID: 21282509 [TBL] [Abstract][Full Text] [Related]
10. Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis. Sohn W; Jun DW; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC Dig Dis Sci; 2015 Nov; 60(11):3340-50. PubMed ID: 26143342 [TBL] [Abstract][Full Text] [Related]
11. TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway. Oh JZ; Kurche JS; Burchill MA; Kedl RM Blood; 2011 Sep; 118(11):3028-38. PubMed ID: 21813451 [TBL] [Abstract][Full Text] [Related]
12. c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types. Drescher HK; Schumacher F; Schenker T; Baues M; Lammers T; Hieronymus T; Trautwein C; Streetz KL; Kroy DC Oxid Med Cell Longev; 2018; 2018():6957497. PubMed ID: 30538805 [TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse. Lee AS; Ghoreishi M; Cheng WK; Chang TY; Zhang YQ; Dutz JP Diabetologia; 2011 Jun; 54(6):1407-16. PubMed ID: 21340621 [TBL] [Abstract][Full Text] [Related]
14. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis. Nishio T; Taura K; Iwaisako K; Koyama Y; Tanabe K; Yamamoto G; Okuda Y; Ikeno Y; Yoshino K; Kasai Y; Okuno M; Seo S; Sakurai T; Asagiri M; Hatano E; Uemoto S J Gastroenterol; 2017 Aug; 52(8):965-976. PubMed ID: 28044208 [TBL] [Abstract][Full Text] [Related]
15. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023 [TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Petrasek J; Dolganiuc A; Csak T; Nath B; Hritz I; Kodys K; Catalano D; Kurt-Jones E; Mandrekar P; Szabo G Hepatology; 2011 Feb; 53(2):649-60. PubMed ID: 21274885 [TBL] [Abstract][Full Text] [Related]
17. STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis. Yu Y; Liu Y; An W; Song J; Zhang Y; Zhao X J Clin Invest; 2019 Feb; 129(2):546-555. PubMed ID: 30561388 [TBL] [Abstract][Full Text] [Related]
19. The TLR7 agonist induces tumor regression both by promoting CD4⁺T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells. Wang C; Zhou Q; Wang X; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L Oncotarget; 2015 Jan; 6(3):1779-89. PubMed ID: 25593198 [TBL] [Abstract][Full Text] [Related]